Insightec secures $150m funding for incisionless neurosurgery technology

Insightec’s Exablate Neuro is claimed to be first MR-guided focused ultrasound device approved by the FDA

Israel-based medical device company Insightec has closed a $150m Series F financing round, led by Koch Disruptive Technologies (KDT) for its Exablate Neuro incisionless neurosurgery device.

Koch Disruptive Technologies (KDT), a subsidiary of Koch Industries, led the funding round with a $100m investment, bringing Insightec’s post-money valuation to $1.3bn.

The funding marks KDT’s second direct investment in INSIGHTEC.

Continue reading…


More To Explore